Bills › 88th General Assembly
Relating to limitations on cost-sharing related to insurance coverage of insulin
Where it is now
- Done: IntroducedJanuary 21, 2020
- Stopped: SubcommitteeDied when the General Assembly ended
- Next: House committee
- Next: Passes the House
- Next: Senate committee
- Next: Passes the Senate
- Next: To the Governor
- Next: Signed into law
Died when the session ended The 2020 session adjourned on June 14, 2020, the General Assembly’s last regular session. Bills that didn’t pass both chambers died. What’s a funnel?
What’s in it
AI summary People with insurance would have a limit on how much they pay for their monthly insulin prescriptions. No matter what type or amount of insulin is needed, the cost-sharing amount cannot be more than $100 for a 30-day supply. Insurance companies are still allowed to charge people even less than this limit if they choose to.1
Read the official explanation
This bill limits the total cost-sharing amount that a covered person is required to pay for covered prescription insulin at an amount not to exceed $100 per 30-day supply of insulin, regardless of the amount or type of insulin needed to fill the covered person’s prescription. Nothing in the bill prevents a carrier from reducing a covered person’s cost sharing by an amount greater than the maximum specified in the bill.